E. Okulu Et Al. , "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion," FRONTIERS IN PEDIATRICS , vol.10, 2022
Okulu, E. Et Al. 2022. Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion. FRONTIERS IN PEDIATRICS , vol.10 .
Okulu, E., Erdeve, O., Kilic, I., Olukman, O., Calkavur, S., Buyukkale, G., ... Cetinkaya, M.(2022). Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion. FRONTIERS IN PEDIATRICS , vol.10.
Okulu, Emel Et Al. "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion," FRONTIERS IN PEDIATRICS , vol.10, 2022
Okulu, Emel Et Al. "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion." FRONTIERS IN PEDIATRICS , vol.10, 2022
Okulu, E. Et Al. (2022) . "Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion." FRONTIERS IN PEDIATRICS , vol.10.
@article{article, author={Emel Okulu Et Al. }, title={Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion}, journal={FRONTIERS IN PEDIATRICS}, year=2022}